{"id":"W2925781938","doi":"10.1016/j.lungcan.2019.02.021","title":"Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"MSD K.K.; Chugai Pharmaceutical; Novartis Pharmaceuticals Canada; Kyowa Hakko Kirin; Eli Lilly Japan; Boehringer Ingelheim","keywords":"Osimertinib; Medicine; T790M; Lung cancer; Internal medicine; Oncology; Epidermal growth factor receptor; Cancer; Erlotinib; Gefitinib","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001273676,0.0002470503,0.0004908442,0.0001532647,0.00005035948,0.00001851176,0.0001161116,0.00013741,0.001483367],"category_scores_gemma":[0.00001495402,0.0002171672,0.0001263599,0.0004152978,0.00004607827,0.0001220219,0.00003072878,0.0001318602,0.00001348511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006135178,"about_ca_system_score_gemma":0.001153365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003182485,"about_ca_topic_score_gemma":0.002416157,"domain_scores_codex":[0.9982244,0.00003697637,0.0005850996,0.0004586726,0.0003142136,0.0003806433],"domain_scores_gemma":[0.9989253,0.00005033779,0.0002838991,0.000449138,0.0001583664,0.000132946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003278433,0.0008472487,0.8418149,0.002636032,0.000786726,0.00008024897,0.005780614,0.0008834287,0.1309322,0.0001197564,0.009706986,0.003133443],"study_design_scores_gemma":[0.0262988,0.001787078,0.6551053,0.006323521,0.004151361,0.000009092444,0.002603766,0.01954913,0.2667192,0.00004746726,0.01602518,0.001380159],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714847,0.007641975,0.00005236203,0.001867445,0.0007124938,0.001818215,0.0001119022,0.00004702782,0.01626387],"genre_scores_gemma":[0.9893658,0.0004673544,0.0003282559,0.0005398823,0.0001586197,0.0005399804,0.0000698486,0.00005242065,0.008477834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1867096,"threshold_uncertainty_score":0.9994294,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01328733990522649,"score_gpt":0.3352145367677815,"score_spread":0.3219271968625549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}